Abstract
Ankylosing spondylitis is an inflammatory disorder primarily affecting the axial skeleton. The disease is associated with increased cardiovascular morbidity and mortality. Structural changes in the heart, and arteriosclerosis secondary to inflammation may be of importance. The role of traditional cardiovascular risk factors and of anti-inflammatory treatment is unclear. Tumor necrosis factor inhibitors seem to increase cholesterol levels. Evaluation of the cardiovascular risk in these patients should be considered. Cardiovascular risk factors should be managed according to ordinary guidelines.
| Translated title of the contribution | [Ankylosing spondylitis is associated with increased cardiovascular morbidity and mortality] |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 173 |
| Issue number | 21 |
| Pages (from-to) | 1503-7 |
| Number of pages | 5 |
| ISSN | 0041-5782 |
| Publication status | Published - May 2011 |